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Intravascular injections or infusions of moderate doses of bacterial pyrogens are 
known to produce biphasic fevers, whereas minimal doses elicit monophasic fevers (1, 
2).  Pyrogen injections into various areas of the brain generally result in monophasic 
fevers, although recently, biphasic fever has been observed after injections of bacterial 
pyrogens into the anterior hypothalamic, preoptic region (3).  Although it is known 
that  the  second  phase  of fever is  associated  temporally with  circulating leukocyte 
pyrogen, host mechanisms responsible for the two phases of the biphasic response are 
not understood (1, 4). 
A  large body of evidence has  accumulated  recently that  supports  the  view that 
prostaglandin E (PGE)I is a primary mediator of fevers induced by bacterial pyrogens 
(5-8). Fevers evoked by injections of enteric bacteria either into the third ventricle or 
proximate to the anterior hypothalamus of the cat  (9) are associated with increased 
PGE levels in cerebrospinal fluid (CSF). Fever, as well as PGE concentrations in CSF, 
decrease after treatment of febrile animals with ant ipyretic compounds (3, 10) known 
to inhibit prostaglandin synthesis (11).  Additional supportive evidence (6,  12) shows 
that  direct  injections of E  prostaglandins  into  the  cerebral  ventricles of cats  and 
rabbits elicit abrupt, monophasic fevers. 
More  recently, however,  the  view  that  PGE  is  the  principal  mediator  of fever 
induced by leukocyte pyrogen (LP) has been challenged by Cranston et al.  (13,  14), 
who effectively dissociated PGE levels in CSF from the fever response to intravenous 
infusions of LP.  They also  found that,  although  intraventricular  injections of PG 
antagonists together with PGE attenuated fever, little or no change in fever response 
resulted when these antagonists were injected simultaneously with LP. Other recent 
evidence (15) casts doubt on the role of PGE in both endotoxin and LP-induced fevers 
because pretreatment of rabbits with cycloheximide prevented fever in rabbits, even 
though PGE concentrations in CSF increased to the levels attained in febrile animals 
not treated with the protein synthesis inhibitor. However, a clear interpretation of the 
latter  experiment  is  complicated  by  the  fact  that  cycloheximide alone  caused  a 
significant decrement in the core temperature of test animals. 
We investigated fever responses in the sheep after the intravascular administration 
of endotoxin and LP with the objective of determining whether PGE or certain other 
oxidation products of arachidonic acid participate in the fever reaction. Part of this 
work has been presented elsewhere (16). 
* Supported by Grants AIHD 12221 and HD 09731 from the National Institutes of Health. 
i Abbreviations used in this paper: CSF, cerebrospinal  fluid; PG, prostaglandin; LP, leukocyte  pyrogen;  RIA, 
radioimmunoassay. 
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Materials and Methods 
Experimental Model.  A group of six anestrous Merino ewes, weighing between 40 and 60 kg, 
were used as subjects; all had equal amounts of wool,  having been shorn on the same day 
several months earlier. At least 6 mo before the start of the experiments, a carotid artery and 
jugular vein were exteriorized and enclosed in a loop of skin from the neck, according to the 
procedure of McDonald et al.  (17). Before  experimental work,  animals were conditioned in 
steel metabolism cages in a temperature-regulated room (23 +  1.5°C). At least one other animal 
was present in the room to prevent isolation stress to which flock animals are susceptible. 
To  minimize the  stress  of blood sampling, infusions, and  injections, sterile  probes  and 
cannulae were positioned on the evening before each experiment. Catheters (Becton, Dickinson 
& Co., Rutherford, N. J.; 20 gauge, 2 in) were placed in the carotid artery and jugular vein 
(within the exteriorized skin loop) and sutured in place using aseptic technique. A Deseret  E-Z 
catheter (Deseret  Pharmaceutical Co., Sandy, Utah;  16 gauge, 8 in) was inserted in the in situ 
jugular vein and sutured in place. A Teflon cannula (16 gauge, 4 in) was placed subcutaneously 
in the flank area for the administration of indomethacin. To prevent clotting, the animals were 
given 20,000  IU of Depot-Heparin (Upjohn Co., Kalamazoo, Mich.). All cannulae were filled 
with heparin (1,000 IU/ml) and closed with three-way stopcocks. 
Blood  pressure  was  monitored  in  the  exteriorized  carotid  artery  using a  conventional 
transducer and preamplifier (Biotronex Laboratory, Inc., Kensington, Md.; ABL-630). Flexible 
Teflon tubing (OD, 3.25 mm; ID, 2.0 mm) ~ 1 m in length connected the intra-arterial cannula 
to  the  transducer. The output  of the  preamplifier was  fed  into a  Grass  polygraph  (Grass 
Instrument Co., Quincy, Mass.)  where mean arterial blood pressure was recorded. A flexible 
Tele  thermometer thermistor  (Yellow  Springs Instrument Co.,  Yellow Springs, Ohio)  was 
inserted 7-10 cm into the vagina and secured in position by sutures anchored in the adjacent 
wool. The output from a thermogauge (Yellow Springs Instrument Co.; model 43 TA) was fed 
into the polygraph and used to monitor the core temperature. Temperature, mean arterial 
blood pressure, and time were recorded simultaneously. The blood pressure transducer was 
calibrated by means of a sphygmomanometer connected at a T junction on the transducer. To 
insure accuracy of the results, thermogauge and blood pressure calibrations were made before 
and after each experiment. 
Approximately 1 h  before each experiment, 8,000  IU of heparin was given intravenously, 
followed  by 5,000  IU every 3 h  thereafter.  When required,  indomethacin was  dissolved in 
sesame oil (10 mg/ml) and administered subcutaneously 1 h before injection or infusion of the 
pyrogen. 
Infusions.  Generally, 1-h infusions of 20-30 ml of normal saline containing endotoxin, LP, 
or PG were administered with a  Harvard infusion pump (Harvard Apparatus Co.,  Inc., S. 
Natick, Mass.). A Millipore membrane (0.45/~m; Millipore Corp., Bedford, Mass.) was fixed to 
the hub of the infusion syringe, and sterile Teflon tubing was used to connect the syringe to the 
intra-arterial catheter.  Control  infusions of sterile saline were  given routinely to  establish 
baseline temperature and blood pressure; both were monitored continuously before, during, 
and after the various infusions. For some experiments, hind-limb infusions of endotoxin were 
administered through a cannula in the left femoral artery. In such instances, the left femoral 
vein was  also  cannulated to  permit  blood  collections from  this  site  as  well  as  from  the 
exteriorized carotid artery and jugular vein. 
Blood Collections.  Blood samples (3.5 ml) were withdrawn simultaneously  from the indwelling 
catheters in the exteriorized carotid artery and the jugular vein. All blood samples were put 
immediately into iced tubes containing 10/~g of indomethacin. Shortly after collection, blood 
samples were centrifuged for 10 min at 1,800 rpm, and the plasma supernates were centrifuged 
a second time to remove any remaining cells. The clarified plasmas were stored in closed tubes 
at -15°C and were later analyzed for PGE and PGF content by radioimmunoassay (RIA). At 
the end of these experiments, animals were given 250  ml of normal whole blood and were 
rested for at least 3 wk before reuse. 
Endotoxin.  A  Boivin preparation of endotoxin  (Salmonella  enteritidis;  Difco  Laboratories, 
Detroit, Mich.) was dissolved in normal saline at 1 mg/ml and stored at -15°C. Before use, the 
stock solution was diluted in isotonic saline. 
Prostaglandins.  PGE~,  PGF2a,  and  PGD2  were  donated  by  Dr.  John  Pike  (Upjohn Co., 1214  PROSTAGLANDIN E  IN  BIPHASIC  FEVER 
Kalamazoo, Mich.), and prostacyclin (PGI2)  was a  girl from Dr. Joseph Fried, University of 
Chicago, Ill. Indomethacin  was donated by the  Merck Chemical  Div., Merck  &  Co.,  Inc., 
Rahway, N. J., and nH-PGE1 (60 Ci/mM) and aH-PGF~ (10.7 Ci/mM) were purchased from 
New England Nuclear, Boston, Mass. With the exception of prostaeyclin (PGI2), the prosta- 
glandins were dissolved in 95% ethanol at  1 mg/ml and stored at -15°C. On the,day of the 
experiment, the required amount  of PG was removed and  suitably diluted in  pyrogen-free 
isotonic saline. A  stock solution (1  mg/ml)  of PGI2 was made up in  15 mM Tris-phosphate 
buffer at pH 9.5 and used within 30 min of preparation. Immediately before infusion, the PGI2 
solution was suitably diluted in isotonic saline adjusted to pH 9.5 with 0.1 N NaOH. 
LP.  Peritoneal exudates were induced in the sheep by the intraperitoneal injection of 3 
liters of normal saline containing 8 #g of S.  enteritidis endotoxin.  12-14 h  later, such animals 
received an infusion of 2.5 liters i. p. of warmed saline containing 10,000 IU of heparin. Cellular 
exudates were then drained from the peritoneal cavity through a  13-gauge needle. After light 
centrifugation, cell pellets were washed once with phosphate-buffered saline (10 mM, pH 7.4) 
and  resuspended in  200  ml fresh buffered saline. The cells were incubated for 2 h  at  37°C 
before rupture by five freeze-thaw cycles. Cellular debris was removed by centrifugation for 30 
min at 5,000 r~am; the clear supernate represented the crude extract of LP. 25 ml of LP extract 
from -2 ×  10  exudate cells (90-94% granulocytes) produced a fever of 0.9-1.2°C. 
RIA.  This procedure has been described elsewhere (18,  19), although the following modi- 
fications were made for this study. Reproducibility of the RIA was verified on both unextracted 
and ethyl acetate-extracted plasma samples containing known quantities of PGE2 or PGF~. In 
contrast to our experience with serum or plasma from several other mammalian species, results 
were more consistent using unextracted sheep plasma, and the RIA data for this study were so 
derived. Before assaying, all test plasmas were spiked with 100 pg of the PG being measured to 
insure that measurements of test samples were obtained from the linear part of standard curves. 
Corrected PG values are expressed as the average of duplicate assays on 0.4-ml vol of each test 
plasma. Standard curves were run each day of assay in the presence of 0.4-ml aliquots of a 
stock supply of normal  sheep  plasma containing no  measurable  PG.  The  tracers used  for 
estimation of PGE and PGF equivalents were sH-PGEa and aH-PGF2~, respectively. 
Results 
Fever Response  to  Endotoxin.  To  establish  the  appropriate  pyrogenic  dose  in  the 
sheep model,  the endotoxin was  given intravascularly, i.e., by the carotid artery or 
jugular vein, either as a  slow infusion or as a  single, brief injection. Doses of 1-2/~g 
per animal produced monophasic fevers that averaged 1.2°C, with a  42-min delay to 
onset of fever (n =  9). Higher doses, 4-10/~g, evoked biphasic fevers averaging 2.1 °C, 
with a  26-min latent period (n =  I0). The route and manner of endotoxin adminis- 
tration made little difference in the fever response except that infusions resulted in a 
slightly longer latent period. 
Representative biphasic fever responses to intracarotid and jugular vein adminis- 
tration of endotoxin are recorded in Figs.  1 and 2.  As is the case with other species, 
the onset  of fever was  accompanied  by shivering.  More  notable,  however,  was  the 
abrupt increase in systemic arterial blood pressure that invariably accompanied fever 
onset. This pressor response ranged from  10 to 20% as the dose of endotoxin increased 
from  1 to  10 ~g. Blood pressure, which rose sharply during the first  10 min of fever, 
gradually diminished during the initial phase and remained normal throughout  the 
second phase of fever. 
PG have been reputed to mediate fever and inasmuch  as we (20)  and others  (21- 
23)  have shown  that  PG appear in the circulation after endotoxin challenge, blood 
samples  were  taken  simultaneously  from  the  carotid  artery  and  jugular  vein  at 
frequent intervals before and during fevers induced by injections or infusions of 4-10 
/~g of endotoxin. In  12 separate experiments, RIA of plasma samples from the carotid SKARNES  ET  AL.  1215 
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Fro.  1.  Fever and pressor responses to an intracarotid  injection of 6 #g of endotoxin  (ET).  The 
plasma levels of PGE and PGF were determined by RIA. Blood samples were withdrawn simuha- 
neously from the carotid artery and jugular vein at 5-min intervals (0-120 min) or 10-min intervals 
(-60 to -5  min and 130-400 min). 
artery and jugular vein affirmed the appearance of PGF and PGE coincident with 
the onset of fever and pressor responses. From the data in Figs.  1 and 2 it is clear that 
(a) the surge of PG correlated well with the initial fever peak (~90 min), and (b) PG 
were not detected throughout the second phase of fever. In two of these experiments, 
additional blood samples were taken from both the femoral artery and femoral vein. 
RIA on plasma from this distal site also revealed the same surge of PGE and PGF 
coincident with the first peak of fever (Fig. 3). 
The transitory appearance of PG  in  both arterial  and  venous plasma  suggested 
that a generalized intravascular synthesis and release of these compounds occurred in 
response to endotoxin. To examine this  possibility  further,  hind-limb  infusions of 
small doses of endotoxin (1-1.5 #g) were given via the femoral artery. Blood plasma 
samples obtained simultaneously from the femoral vein, carotid artery, and jugular 
vein were subjected to RIA. Representative results of these assays are shown in Fig. 
4, where it is seen that PGE appeared in plasma from the femoral and jugular veins 
~30  min  from the start of infusion. The time of appearance of PG  in  the venous 
circulation coincided with the rise in temperature and blood pressure. However, these 
small doses of endotoxin elicited barely detectable amounts of PG in carotid arterial 
plasma. 
Fever Response to PG.  The appearance of PGE and PGF in the general circulation 1216  PROSTAGLANDIN  E  IN  BIPHASIC  FEVER 
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FIG.  2.  Fever and pressor responses to a jugular vein infusion of 6 #g of endotoxin  (ET).  Blood 
samples for PG assays were collected from the carotid artery and jugular vein at  10-min intervals 
throughout the experiment. A surge of PGF in arterial and venous plasma during the initial fever 
(not shown) closely paralleled that of PGE. 
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FIG.  3.  Fever response to an intracarotid  injection of 10 #g of endotoxin (ET).  Blood collections 
for  the PG assay were  taken simultaneously from the femoral artery  and femoral  vein at  5-min 
intervals (0-120 min) or 10-min intervals(-60 to -5  min and 130-360 min). SKARNES ET AL. 
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FIG. 4.  Fever  and pressor responses to a femoral artery infusion of 1.5 ~g of endotoxin (ET). 
Simultaneous blood collections for PGE assay were taken at 10-min intervals from the jugular vein, 
femoral vein, and carotid artery. 
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during the early phase of endotoxin fever led us to investigate the pyrogenic effects of 
infusions of exogenous PG.  Intravenous infusions did not alter core temperature or 
blood pressure, presumably because of the rapid metabolism of PG by the liver and 
lung (24, 25). Intracarotid infusions of PGE2, however, evoked abrupt fever and blood 
pressure  responses at doses ranging from 60 to  160 #g (1-2.7 ~g/min).  By contrast, 
carotid arterial infusions of 60-1,500 ~g (1-25/xg/min) of PGF2a consistently produced 
nominal  decrements  in  core  temperature  (0.1-0.2°C)  and  had  no  effect  on  blood 
pressure (Fig.  5). 
The fever response to PGE2 was monophasic, with an average duration of-3  h. 
Infusions of 80-100 Fg (1.3-1.7/xg/min) produced fevers averaging 0.9°C, with a time 
of onset of 5-8 min (n =  7);  140-160/~g (2.3-2.7/xg/min) evoked fevers of 1.2°C, with 
a  time of onset of 3-5 min (n -- 7). The pressor response to PGE2 was slightly faster, 
occurring within 1-3 min of the start of infusion. The magnitude of the blood pressure 
increment ranged from 10 to 25% in a dose-dependent manner. 
lndomethacin Inhibition of Fever.  The preceding results clearly imply an essential role 
for PGE in the initial  fever and pressor responses to circulating endotoxin.  Further 
support  for this  interpretation  was obtained  in  experiments  with  indomethacin,  a 
potent inhibitor of arachidonate metabolism. Because intra-arterial infusions of 5-10 
/~g/ml of indomethacin together with endotoxin had little or no effect on the fever 
response, indomethacin was given subcutaneously in sesame oil before infusions of the 
toxin. Complete inhibition of both fever and pressor responses was obtained consis- 
tently with  a  single  dose of 4  mg/kg of indomethacin  given  1 h  before endotoxin 
challenge  (Fig.  6).  Lesser amounts of indomethacin  (2-3 mg/kg) resulted  in partial 
attenuation of fever, whereas no effect was seen at  1 mg/kg. PG were not measureable 
in carotid artery and jugular vein plasma from endotoxin-treated animals receiving 
4 mg/kg indomethacin, nor was a pressor effect observed. Control subjects pretreated 1218  PROSTAGLANDIN  E  IN  BIPHASIC  FEVER 
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Fro.  5.  Body temperature and pressor responses to intracarotid infusions  of PGE2 (2.6 ~g/min) 
and PGF~ (1.3-25.0 gg/min). 
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FIG. 6.  Effect of indomethacin pretreatment (4 mg/kg, subcutaneously)  on the fever and pressor 
responses to an intracarotid infusion  of 10/~g of endotoxin (ET).  PG assays of carotid artery and 
jugular vein plasma collected at  10-rain intervals throughout the experiment indicated the absence 
of PGE and PGF. In control animals pretreated with indomethacin, both fever and pressor responses 
to intracarotid infusions of PGE2 remained unchanged. 
with this amount of indomethacin responded in characteristic fashion to infusions of 
PGE2, as indicated in Fig. 6. 
Fever Response  to  LP.  Our  results  show  that  neither  PGE  nor  PGF  mediate  the 
second phase of the biphasic fever response to endotoxin.  However, the finding that 
indomethacin  blocked  the  total  fever  response  suggested  a  role  for  some  other 
pyrogenic metabolite of arachidonic acid in the late phase. To clarify this point, we SKARNES  ET  AL.  1219 
investigated  the  fever  response  of the  sheep  to  LP,  the  circulating  endogenous 
protein(s) associated with the second phase of endotoxin-induced fever. 
Intracarotid infusions of crude LP gave rise to monophasic fevers averaging 1.0°C, 
with  latencies  of 15-20  min  (n  =  6).  Blood  pressure  changes  were  not  seen,  and 
frequent blood collections from the carotid artery and jugular vein before and during 
fever episodes showed the absence of PGE and PGF in plasma samples subjected to 
RIA. Pretreatment of animals with indomethacin abolished the fever response, as seen 
in Fig. 7. 
The inhibition by indomethacin of  both endotoxin and LP fever responses prompted 
us  to  investigate  the  possible  pyrogenic  action  of other  available  metabolites  of 
arachidonic acid. Carotid arterial infusions of prostacyclin (PGI2) produced neither 
fever nor pressor effects at doses of 2.5 or 6.6 #g/min, although cardiac arrhythmia 
was observed at the higher concentration. Infusions of 2.5 or 6.6 #g/rain of PGD2 did 
not  produce  fever but  did  evoke  pressor  responses  equivalent  to  those  of PGE2. 
Representative results from these experiments are given in Fig. 8. 
Discussion 
The role of PG in the pathogenesis of fever induced by endotoxins or leukocyte 
(endogenous) pyrogens is currently unresolved. Recent work on this subject has led to 
discordant observations and interpretations, which may relate to the common practice 
of administering  pyrogens by extravascular route.  In  the  present  study,  pyrogenic 
agents were given intravascularly by slow infusions or brief injections to simulate 
events that  might occur during the course of an enteric bacteremia. This approach 
proved fruitful in  that  a  clear delineation of the  two phases  of the biphasic  fever 
response was made possible. 
The use of the sheep as a  model for this study was particularly advantageous for 
the following reasons.  The fever response was  monitored in conscious, conditioned 
animals, and injections, infusions, and blood sampling were done with minimal stress 
to the subjects. The blood volume of the sheep is sufficiently large to permit frequent 
collections of the many blood samples required in this investigation. Unlike plasma or 
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FIG. 8.  Effects of intracarotid infusions of PGI2 (6.6 ptg/min) or PGD2 (2.6 /~g/min) on body 
temperature and blood pressure. 
serum  from  other  mammalian  species  that  we  have  studied  (mouse,  rat,  rabbit, 
monkey, and human), ovine plasma was free of components that interfere with RIA, 
and the need to extract plasma samples was thereby avoided. 
In taking simultaneous blood collections from the carotid artery and jugular vein 
during fever episodes, it was anticipated that plasma PG levels, if detectable, would 
show obvious arterio-venous differences across the brain during fever. This was not 
the case, however, in animals receiving 4-10 #g of endotoxin.  In such experiments, 
arterial plasma contained nearly as much PG as plasma from the jugular vein. The 
presence  of PG  in  carotid  arterial  plasma  suggests  that  either  PG  synthesis  (and 
release) by the lung is increased or that  PG metabolism is compromised during the 
initial  phase of fever. The latter possibility is more probable because of reports of a 
marked inhibition of PG metabolism in lung and liver preparations from endotoxin- 
treated animals (26,  27). 
When animals were given infusions of <2/xg of endotoxin, significant arteriovenous 
differences in  PG content  of plasma were observed  (Fig.  4).  Little or no  PGE was 
present in carotid plasma, whereas a  surge of PGE appeared in jugular vein plasma 
coincident  with  the  first  fever peak and pressor response•  These experiments imply 
that  very small doses of endotoxin  do not  impair PG metabolism in  the lung,  and 
they suggest that the fever response can be initiated by a  local synthesis and release 
of PG  in  the  cranial  vasculature.  There  is  little  doubt  that  with  higher  doses  of 
endotoxin,  the resultant surge of PGE from the carotid artery serves to magnify the 
early temperature rise and pressor effect. 
Of the PG tested, only PGE2 evoked a  fever response when infused via the carotid 
artery. The specificity of PGE2 as a  pyrogen is striking considering the fact that the 
structurally similar PGD~ compound did not produce fever, even though it appeared 
to be equipotent as a pressor agent. The abrupt pressor effect of intracarotid infusions 
of PGEz has been found  to be centrally mediated  (28),  and  it is probable that  the 
early  temperature  and  pressor  responses  to  circulating  endotoxin  are  also  central 
effects mediated by PGE. SKARNES  ET  AL.  1221 
The close temporal relationship between the appearance of PGE in the circulation 
and the rapid onset of fever and pressor responses to endotoxin mirrored the responses 
obtained with intracarotid infusions of PGE2. This observation implies that the early 
temperature and blood pressure responses to endotoxin are initiated by PGE generated 
in the blood compartment and that this PG diffuses rapidly across the blood-brain 
interface to act  on appropriate receptors in  the brain.  In  preliminary experiments 
(Kolb, Bovaird, and McCracken, unpublished results), PG has been identified by RIA 
in the CSF of the sheep within 3 min from the start of intracarotid infusions and in 
jugular vein plasma within 3 min of intraventricular administration of PG. 
Although it was anticipated that  indomethacin would attenuate the initial  fever 
and  pressor responses  to  endotoxin, we  did  not  expect a  total  inhibition  of fever 
because plasma RIA indicated the absence of PGE (and pressor effect) during the late 
phase. This finding is compatible, however, with the observed indomethacin block of 
the LP fever response which, according to our data, is not associated with circulating 
PGE. The work of Cranston  and colleagues  (13,  14)  provides more direct evidence 
that PGE does not mediate LP fever, even when this pyrogen is administered via a 
lateral cerebral ventricle. 
In  the  aggregate,  our results  implicate  PGE  as  the  mediator of the  early  fever 
response to circulating endotoxin and suggest that an additional pyrogenic derivative 
of arachidonate  metabolism  is  responsible  for  the  second  phase  of the  biphasic 
response. Support for this view is found in the work of Laburn et al. (29), who showed 
that whereas indomethacin effectively diminished the temperature response to intra- 
ventricular injections of sodium arachidonate,  PG antagonists  attenuated  only the 
early part of the fever response when coinjected with arachidonate. 
The PGE associated with the initial fever response may originate, in part, from the 
macrophage because this cell has been shown to synthesize and release PGE when 
exposed to endotoxin in vitro (30). It is also conceivable that circulating LP provides 
an  additional stimulus  for pyrogen release from cells such  as  granulocytes, macro- 
phages, and platelets, all of which are capable of producing primary PG, endoper- 
oxides, and/or thromboxanes (31-36). Rather than assume a direct action of LP on 
thermoregulatory centers in the brain, we favor the thesis that  the second phase of 
fever is,  like the  early phase,  mediated  by a  pyrogenic derivative of arachidonate 
metabolism produced by cells within the blood compartment. Accordingly, the total 
biphasic fever response to endotoxin may reflect a sequential transport of pyrogenic 
metabolites across the blood-brain interface. 
Summary 
Biphasic fevers were induced in sheep with intravascular infusions or injections of 
4-10 #g (80-200 ng/kg) of endotoxin, whereas monophasic fevers were obtained with 
doses of 1-2/xg (20-40 ng/kg). A marked increase in arterial blood pressure invariably 
accompanied the onset of fever; the latency of responses to the higher and lower doses 
of endotoxins averaged 26 min and 42 min, respectively. Prostaglandin (PG) assays of 
plasma from the carotid artery and jugular vein during fever episodes revealed a surge 
of PGE and PGF coincident with the pressor response and the first phase of fever, but 
PG were not detected in plasma samples taken throughout the second phase of fever. 
PG measurements of arterial and venous plasma collected at a distal site (hind limb) 
showed a similar surge of PGE and PGF in association with the early fever response, 1222  PROSTAGLANDIN  E IN BIPHASIC FEVER 
indicating  that  intravascular  PG synthesis  and  release  represents  a  generalized  sys- 
temic response to circulating endotoxin. Carotid arterial  infusions of PGE2 produced 
immediate monophasic fevers and pressor responses, whereas PGD2 infusions produced 
an immediate pressor effect but no fever. Infusions of PGF2~ or prostacyclin, however, 
evoked neither  fever nor pressor effects.  Intracarotid  infusions of leukocyte pyrogen 
(LP) caused monophasic fevers with latent periods of 15-20 min but pressor responses 
were not seen and neither  PGE nor PGF were detected  in plasma samples from the 
carotid artery or jugular vein before or during fever. Indomethacin, a potent inhibitor 
of arachidonic  acid  metabolism,  blocked  fever  responses  to  endotoxin  and  to  LP. 
These findings implicate  PGE as the mediator of the early phase of endotoxin  fever 
and imply a role for another pyrogenic metabolite ofarachidonic acid in the mediation 
of the second phase of fever, i.e., the phase associated with circulating LP. It is possible 
that  both  pyrogenic  metabolites  are  generated  within  the  vascular  compartment, 
reaching  thermoregulatory  centers  of the  brain  by transfer  across  the  blood-brain 
interface. 
Received for publication  26 May 1981. 
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